Stock ELDN ELEDON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Eledon Pharmaceuticals, Inc.

Equities

ELDN

US28617K1016

Market Closed - Nasdaq
Other stock markets
 01:30:00 08/06/2024 am IST 		5-day change 1st Jan Change
2.78 USD +2.21% Intraday chart for Eledon Pharmaceuticals, Inc. +1.09% +54.44%
03/06 Eledon Pharmaceuticals, Inc. Presents Updated Data from Ongoing Phase 1B Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation CI
13/05 Eledon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ELEDON PHARMACEUTICALS, INC. Stock Eledon Pharmaceuticals, Inc.
 107M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 108B
BIONTECH SE Stock BioNTech SE
 24.21B -
ARGENX SE Stock argenx SE
 22.78B -
GENMAB A/S Stock Genmab A/S
 17.96B
  1. Stock Market
  2. Equities
  3. ELDN Stock
  4. Charts Eledon Pharmaceuticals, Inc.
  5. Sector Chart